SUTRO BIOPHARMA INC (STRO:NASDAQ)
$26.19 0.33 (1.2761%)
Analysed SUTRO BIOPHARMA INC (STRO:NASDAQ) News Sources
Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?
08-04-2026
yahoo.com
Arm downgraded, Arista Networks upgraded: Wall Street's top analyst calls
07-04-2026
yahoo.com
Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?
01-04-2026
yahoo.com
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
23-03-2026
yahoo.com
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
03-03-2026
yahoo.com
Sutro Biopharma to Participate in Upcoming Investor Conferences
25-02-2026
yahoo.com
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
23-02-2026
yahoo.com
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
11-02-2026
yahoo.com
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
10-02-2026
yahoo.com
Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake
10-02-2026
yahoo.com
What is the current price of SUTRO BIOPHARMA INC (STRO:NASDAQ)?
The current price of SUTRO BIOPHARMA INC (STRO:NASDAQ) is $26.19.
SUTRO BIOPHARMA INC (STRO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUTRO BIOPHARMA INC (STRO:NASDAQ) since the previous trading day is $0.33.
SUTRO BIOPHARMA INC (STRO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUTRO BIOPHARMA INC (STRO:NASDAQ) since the previous trading day is 1.2761%.
What is the most recent average sentiment score for SUTRO BIOPHARMA INC (STRO:NASDAQ)?
The most recent average sentiment score for SUTRO BIOPHARMA INC (STRO:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for SUTRO BIOPHARMA INC (STRO:NASDAQ)?
The most recent sentiment for SUTRO BIOPHARMA INC (STRO:NASDAQ) is .
SEC-8K** Filing Available For SUTRO BIOPHARMA INC (STRO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.